Published online 9 August 2004. doi:10.1083/jcb.200401139
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 166, Number 4, 507-516
Chfr acts with the p38 stress kinases to block entry to mitosis in mammalian cells
Takahiro Matsusaka and
Jonathon Pines
Wellcome/Cancer Research UK Gurdon Institute, and Department of Zoology, University of Cambridge, Cambridge CB2 1QR, England, UK
Address correspondence to J. Pines, Wellcome/Cancer Research UK Gurdon Institute, and Dept. of Zoology, Tennis Court Rd., University of Cambridge, Cambridge CB2 1QR, England, UK. Tel: 1223 334096. Fax: 1223 334089. email: j.pines{at}welc.cam.ac.uk
Entry into mitosis in vertebrate cells is guarded by a checkpoint that can be activated by a variety of insults, including chromosomal damage and disrupting microtubules (Rieder, C.L., and R.W. Cole. 1998. J. Cell Biol. 142:10131022; Rieder, C.L., and R.W. Cole. 2000. Curr. Biol. 10:10671070). This checkpoint acts at the end of interphase to delay cells from entering mitosis, causing cells in prophase to decondense their chromosomes and return to G2 phase. Here, we show that in response to microtubule poisons this "antephase" checkpoint is primarily mediated by the p38 stress kinases and requires the Chfr protein that is absent or inactive in several transformed cell lines (Scolnick, D.M., and T.D. Halazonetis. 2000. Nature. 406:430435) and lung tumors (Mizuno, K., H. Osada, H. Konishi, Y. Tatematsu, Y. Yatabe, T. Mitsudomi, Y. Fujii, and T. Takahashi. 2002. Oncogene. 21:23282333). Furthermore, in contrast to previous reports, we find that the checkpoint requires ubiquitylation but not proteasome activity, which is in agreement with the recent demonstration that Chfr conjugates ubiquitin through lysine 63 and not lysine 48 (Bothos, J., M.K. Summers, M. Venere, D.M. Scolnick, and T.D. Halazonetis. 2003. Oncogene. 22:71017107).
Key Words: checkpoint; ubiquitin; cyclin; phosphorylation; proteolysis

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Balestra, F. R., Jimenez, J.
(2008). A G2-Phase Microtubule-Damage Response in Fission Yeast. Genetics
180: 2073-2080
[Abstract]
[Full Text]
-
Privette, L. M., Gonzalez, M. E., Ding, L., Kleer, C. G., Petty, E. M.
(2007). Altered Expression of the Early Mitotic Checkpoint Protein, CHFR, in Breast Cancers: Implications for Tumor Suppression. Cancer Res.
67: 6064-6074
[Abstract]
[Full Text]
-
Perez de Castro, I., de Carcer, G., Malumbres, M.
(2007). A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis
28: 899-912
[Abstract]
[Full Text]
-
Chin, K.-T., Chun, A. C.S., Ching, Y.-P., Jeang, K.-T., Jin, D.-Y.
(2007). Human T-Cell Leukemia Virus Oncoprotein Tax Represses Nuclear Receptor-Dependent Transcription by Targeting Coactivator TAX1BP1. Cancer Res.
67: 1072-1081
[Abstract]
[Full Text]
-
Shiromizu, T., Goto, H., Tomono, Y., Bartek, J., Totsukawa, G., Inoko, A., Nakanishi, M., Matsumura, F., Inagaki, M.
(2006). Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1).. GENES CELLS
11: 477-485
[Abstract]
[Full Text]
-
Mikhailov, A., Shinohara, M., Rieder, C. L.
(2004). Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. JCB
166: 517-526
[Abstract]
[Full Text]